1985 — 1991

Ιατρική Σχολή Πανεπιστημίου Ιωαννίνων

2015 — 2018

Παθολόγος, Νοσοκομείο "ΙΑΣΩ GENERAL", Αθήνα

2014 — 2015

Επιμελητής Λοιμωξιολογικής Κλινικής, Νοσοκομείο "ΙΑΣΩ GENERAL", Αθήνα

2012 — 2014

Επιμελητής Παθολογικής - Λοιμωξιολογικής Κλινικής, Νοσοκομείο "Μητέρα" - Όμιλος "Υγεία", Αθήνα

2006 — 2010

Αναπληρωτής Διευθυντής Λοιμωξιολογικού Τμήματος, Νοσοκομείο "Ερρίκος Ντυνάν", Αθήνα

2004 — 2016

Πρόεδρος Επιτροπής Ανάπτυξης, Άλφα Ινστιτούτο Βιοϊατρικών Επιστημών (ΑΙΒΕ), Αθήνα

2003 — 2006

Επιμελητής Λοιμωξιολογικού Ιατρείου, Νοσοκομείο "Ερρίκος Ντυνάν", Αθήνα

1999 — 2003

Αναπληρωτής Αρχίατρος, MEDI SYSTEM INTERAMERICAN

1999 — 2003

Υποψήφιος Διδάκτορας, Δ΄ Παθολογική Κλινική, Καθ. Ε. Γιαμαρέλλου, "Σισμανόγλειο" Γενικό Νοσοκομείο Αττικής

1997 — 2000

Μέλος της Επιστημονικής Επιτροπής του "Σισμανογλείου" Γενικού Νοσοκομείου Αττικής

1995 — 2000

Ειδικευόμενος Ιατρός στην Παθολογία, “Σισμανόγλειο” Γενικό Νοσοκομείο Αττικής

1994 — 1995

Αγροτικός Ιατρός Κορωνίδας Νάξου

1992 — 1993

Ιατρός Στρατιωτικής Μονάδας 117 Π.Μ. , Ιατρός 251 Γ.Ν.Α. (Στρατιωτική θητεία στην Πολεμική Αεροπορία).

13 Δεκ. 2015

11ος Δεκάλογος για τις λοιμώξεις.
Διατομεακό Επιστημονικό Σεμινάριο
(Αμφιθέατρο Ομίλου ΙΑΣΩ)

13 Δεκ. 2014

10ος Δεκάλογος για τις λοιμώξεις.
Διατομεακό Επιστημονικό Σεμινάριο
(Αμφιθέατρο Ερρίκος Ντυνάν, Hospital Center)

7 Δεκ. 2013

9ος Δεκάλογος για τις λοιμώξεις.
Διατομεακό Επιστημονικό Σεμινάριο
(Συνεδριακό Κέντρο "Ν.Λούρος", Νοσοκομείο Μητέρα)

15 Δεκ. 2012

8ος Δεκάλογος για τις λοιμώξεις.
Διατομεακό Επιστημονικό Σεμινάριο
(Συνεδριακό Κέντρο "Ν.Λούρος", Νοσοκομείο Μητέρα)

12 Νοεμ. 2011

7ος Δεκάλογος για τις λοιμώξεις.
Διατομεακό Επιστημονικό Σεμινάριο
(Ξενοδοχείο "Hilton")

20 Νοεμ. 2010

6ος Δεκάλογος για τις λοιμώξεις.
Διατομεακό Επιστημονικό Σεμινάριο
(Ξενοδοχείο "Hilton")

13 Μαρτ. 2009

5ος Δεκάλογος για τις λοιμώξεις.
Διήμερο Διατομεακό Επιστημονικό Σεμινάριο
(Ξενοδοχείο "Hilton")

Φεβρ. 2008

4ος Δεκάλογος για τις λοιμώξεις.
Τριήμερο Διατομεακό Επιστημονικό Σεμινάριο

Φεβρ. 2007

3ος Δεκάλογος για τις λοιμώξεις.
Τριήμερο Διατομεακό Επιστημονικό Σεμινάριο

Φεβρ. 2005

2ος Δεκάλογος για τις λοιμώξεις.
Τριήμερο Διατομεακό Επιστημονικό Σεμινάριο

Φεβρ. 2005

1ος Δεκάλογος για τις λοιμώξεις.
Τριήμερο Διατομεακό Επιστημονικό Σεμινάριο

1. Vacuum-assisted closure versus closure without vacuum assistance for preventing surgical site infections and infections of chronic wounds: a meta-analysis of randomized controlled trials. Tansarli GS, Vardakas KZ, Stratoulias C, Peppas G, Kapaskelis A, Falagas ME. Surg Infect (Larchmt). 2014 Aug;15(4):363-7. doi: 10.1089/sur.2013.028. Epub 2014 May 8.
2. Proportion of extended-spectrum β-lactamase (ESBL)-producing isolates among Enterobacteriaceae in Africa: evaluation of the evidence--systematic review. Tansarli GS, Poulikakos P, Kapaskelis A, Falagas ME. J Antimicrob Chemother. 2014 May;69(5):1177-84. doi: 10.1093/jac/dkt500. Epub 2014 Jan 6.
3. Trends of mortality due to septicemia in Greece: an 8-year analysis. Falagas ME, Korbila IP, Kapaskelis A, Manousou K, Leontiou L, Tansarli GS. PLoS One. 2013 Jul 2;8(7):e67621. doi: 10.1371/journal.pone.0067621. Print 2013.
4. Impact of vacuum-assisted closure (VAC) therapy on clinical outcomes of patients with sternal wound infections: a meta-analysis of non-randomized studies. Falagas ME, Tansarli GS, Kapaskelis A, Vardakas KZ. PLoS One. 2013 May 31;8(5):e64741. doi: 10.1371/journal. pone.0064741. Print 2013.
5. Iron deficiency and susceptibility to infections: evaluation of the clinical evidence. Tansarli GS, Karageorgopoulos DE, Kapaskelis A, Gkegkes I, Falagas ME. Eur J Clin Microbiol Infect Dis. 2013 Oct;32(10):1253-8. doi: 10.1007/s10096-013-1877-x. Epub 2013 Apr 18.
6. Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence. Tansarli GS, Karageorgopoulos DE, Kapaskelis A, Falagas ME. Expert Rev Anti Infect Ther. 2013 Mar;11(3):321-31. doi: 10.1586/eri.13.4. Review.
7. Ertapenem use and antimicrobial resistance to group 2 carbapenems in Gram-negative infections: a systematic review. Falagas ME, Tansarli GS, Kapaskelis A, Vardakas KZ. Expert Rev Anti Infect Ther. 2013 Jan;11(1):69-78. doi: 10.1586/eri.12.149. Review.
8. Frequency of the off-label use of antibiotics in clinical practice: a systematic review. Tansarli GS, Rafailidis PI, Kapaskelis A, Falagas ME. Expert Rev Anti Infect Ther. 2012 Dec;10(12):1383-92. doi: 10.1586/eri.12.137. Review.
9. Impact of antibiotic MIC on infection outcome in patients with susceptible Gram-negative bacteria: a systematic review and meta-analysis. Falagas ME, Tansarli GS, Rafailidis PI, Kapaskelis A, Vardakas KZ. Antimicrob Agents Chemother. 2012 Aug;56(8):4214-22. doi: 10.1128/AAC.00663-12. Epub 2012 May 21. Review.
10. Ventilator-associated sinusitis in adults: systematic review and meta-analysis. Agrafiotis M, Vardakas KZ, Gkegkes ID, Kapaskelis A, Falagas ME. Respir Med. 2012 Aug;106(8):1082-95. doi: 10.1016/j.rmed.2012.03.009. Epub 2012 Apr 20. Review.
11. Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. Karageorgopoulos DE, Vouloumanou EK, Korbila IP, Kapaskelis A, Falagas ME. PLoS One. 2011;6(7):e21690. doi: 10.1371/journal.pone.0021690. Epub 2011 Jul 1.
12. Association between thyroid function tests at baseline and the outcome of patients with sepsis or septic shock: a systematic review. Angelousi AG, Karageorgopoulos DE, Kapaskelis AM, Falagas ME. Eur J Endocrinol. 2011 Feb;164(2):147-55. doi: 10.1530/EJE-10-0695. Epub 2010 Nov 15. Review.
13. Antiviral treatment for severe EBV infections in apparently immunocompetent patients. Rafailidis PI, Mavros MN, Kapaskelis A, Falagas ME. J Clin Virol. 2010 Nov;49(3):151-7. doi: 10.1016/j.jcv.2010.07.008. Epub 2010 Aug 24. Review.
14. Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere. Falagas ME, Cholevas NV, Kapaskelis AM, Vouloumanou EK, Michalopoulos A, Rafailidis PI. Eur J Clin Microbiol Infect Dis. 2010 Nov;29(11):1327-47. doi: 10.1007/s10096-010-1002-3. Epub 2010 Jul 13. Review.
15. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. Falagas ME, Vouloumanou EK, Togias AG, Karadima M, Kapaskelis AM, Rafailidis PI, Athanasiou S. J Antimicrob Chemother. 2010 Sep;65(9):1862-77. doi: 10.1093/jac/dkq237. Epub 2010 Jun 29. Review.
16. Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials. Samonis G, Maraki S, Rafailidis PI, Kapaskelis A, Kastoris AC, Falagas ME. Future Microbiol. 2010 Jun;5(6):961-70. doi: 10.2217/fmb.10.47.
17. Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. Falagas ME, Koletsi PK, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Rello J. J Antimicrob Chemother. 2010 Jul;65(7):1330-46. doi: 10.1093/jac/dkq158. Epub 2010 May 20.
18. Antimicrobial susceptibility of Gram-positive non-urinary isolates to fosfomycin. Falagas ME, Maraki S, Karageorgopoulos DE, Kastoris AC, Kapaskelis A, Samonis G. Int J Antimicrob Agents. 2010 May;35(5):497-9. doi: 10.1016/j.ijantimicag.2010.01.010. Epub 2010 Mar 11.
19. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Lancet Infect Dis. 2010 Jan;10(1):43-50. doi: 10.1016/S1473-3099(09)70325-1. Review.
20. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Falagas ME, Rafailidis PI, Ioannidou E, Alexiou VG, Matthaiou DK, Karageorgopoulos DE, KapaskelisA, Nikita D, Michalopoulos A. Int J Antimicrob Agents. 2010 Feb;35(2):194-9. doi: 10.1016/j.ijantimicag.2009.10.005. Epub 2009 Dec 16
21. Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Falagas ME, Kastoris AC, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Dimopoulos G. Future Microbiol. 2009 Nov;4(9):1103-9. doi: 10.2217/fmb.09.84. Review.
22. Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children. Karageorgopoulos DE, Valkimadi PE, Kapaskelis A, Rafailidis PI, Falagas ME. Arch Dis Child. 2009 Aug;94(8):607-14. doi: 10.1136/adc.2008.151563. Review.
23. Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence. Falagas ME, Kapaskelis AM, Kouranos VD, Kakisi OK, Athanassa Z, Karageorgopoulos DE. Drugs. 2009 Jul 9;69(10):1351-61. doi: 10.2165/00003495-200969100-00005. Review.
24. Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials. Vouloumanou EK, Karageorgopoulos DE, Kazantzi MS, Kapaskelis AM, Falagas ME. J Antimicrob Chemother. 2009 Jul;64(1):16-24. doi: 10.1093/jac/dkp166. Epub 2009 May 19. Review.
25. High prevalence of antibody titers against Bordetella pertussis in an adult population with prolonged cough. Kapaskelis AM, Vouloumanou EK, Rafailidis PI, Hatzopoulou P, Nikita D, Falagas ME. Respir Med. 2008 Nov;102(11):1586-91. doi: 10.1016/j.rmed.2008.06.001. Epub 2008 Aug 6.
26. Effectiveness and safety of short-course vs long-course antibiotic therapy for group a beta hemolytic streptococcal tonsillopharyngitis: a meta-analysis of randomized trials. Falagas ME, Vouloumanou EK, Matthaiou DK, Kapaskelis AM, Karageorgopoulos DE. Mayo Clin Proc. 2008 Aug;83(8):880-9.
27. Henoch-Schönlein purpura associated with Proteus mirabilis urinary tract infection. Rafailidis PI, Kapaskelis A, Falagas ME. J Am Acad Dermatol. 2008 May;58(5 Suppl 1):S98-9. doi: 10.1016/j.jaad.2007.01.018. No abstract available.
28. Concurrent M. tuberculosis, Klebsiella pneumoniae, and Candida albicans infection in liver metastasis of bowel carcinoma. Rafailidis PI, Kapaskelis A, Christodoulou C, Galani E, Falagas ME. Eur J Clin Microbiol Infect Dis. 2008 Aug;27(8):753-5. doi: 10.1007/s10096-008-0488-4. Epub 2008 Feb 26.
29. Multifocal Pseudomonas aeruginosa myositis in an apparently healthy adult. Rafailidis PI, Kapaskelis A, Falagas ME. Eur J Clin Microbiol Infect Dis. 2008 Feb;27(2):159-61. Epub 2007 Nov 8. No abstract available.
30. Cytomegalovirus meningitis in an immunocompetent patient. Rafailidis PI, Kapaskelis A, Falagas ME. Med Sci Monit. 2007 Sep;13(9):CS107-109.
31. Pyomyositis associated with hematological malignancy: case report and review of the literature. Falagas ME, Rafailidis PI, Kapaskelis A, Peppas G. Int J Infect Dis. 2008 Mar;12(2):120-5. Epub 2007 Aug 27. Review.
32. Periorbital and facial swelling due to dermatomyositis. Rafailidis PI, Kapaskelis A, Falagas ME. CMAJ. 2007 May 22;176(11):1580-1.
33. Knee septic arthritis due to Streptococcus pyogenes associated with acute thrombosis of the tibial and peroneal veins: case report and review of the literature. Rafailidis PI, Kapaskelis A, Falagas ME. Scand J Infect Dis. 2007;39(4):368-70. Review.
34. Characterisation of macrolide-non-susceptible Streptococcus pneumoniae colonising children attending day-care centres in Athens, Greece during 2000 and 2003. Souli M, Volonakis K, Kapaskelis A, Galani I, Grammelis V, Vorou R, Tsivra M, Chryssouli Z, Katsala D, Giamarellou H. Clin Microbiol Infect. 2007 Jan;13(1):70-7.
35. Evolution of resistance patterns and identification of risk factors for Streptococcus pneumoniae colonisation in daycare centre attendees in Athens, Greece. Volonakis K, Souli M, Kapaskelis A, Baziaka F, Grammelis V, Ziakas PD, Giamarellou H. Int J Antimicrob Agents. 2006 Oct;28(4):297-301. Epub 2006 Sep 7.
36. Limitations in the management of aortic graft infections. Bliziotis IA, Kapaskelis AM, Kasiakou SK, Falagas ME. Ann Vasc Surg. 2006 Sep;20(5):669-71. Epub 2006 May 27.
37. Red streaks on the leg. Lymphangitis. Falagas ME, Bliziotis IA, Kapaskelis AM. Am Fam Physician. 2006 Mar 15;73(6):1061-2. No abstract available.
38. Mesh-related infection after hernia repair: case report of an emerging type of foreign-body related infection. Bliziotis IA, Kasiakou SK, Kapaskelis AM, Falagas ME. Infection. 2006 Feb;34(1):46-8.
39. Cure of multidrug-resistant Acinetobacter baumannii fixation device-related orthopedic infections in two patients with intravenous colistin. Kasiakou SK, Fragoulis K, Tzagarakis G, Mistidis P, Kapaskelis A, Falagas ME. Microb Drug Resist. 2005 Fall;11(3):287-9.
40. Regression of skin lesions of Kyrle's disease with clindamycin: implications for an infectious component in the etiology of the disease. Kasiakou SK, Peppas G, Kapaskelis AM, Falagas ME. J Infect. 2005 Jun;50(5):412-6.
41. Association between Wegener's granulomatosis and increased antithyroid antibodies: report of two cases and review of the literature. Rosmarakis ES, Kapaskelis AM, Rafailidis PI, Falagas ME. Int J Clin Pract. 2005 Mar;59(3):373-5.
42. Case report: Wegener's granulomatosis presents as pulmonary infection. Rosmarakis ES, Kapaskelis AM, Kasiakou SK, Falagas ME. Am Fam Physician. 2005 Mar 15;71(6):1062, 1064. Erratum in: Am Fam Physician. 2005 Aug 15;72(4):574. Rosmarakis, ES [added]; Kapaskelis, AM [added]; Kasiakou, SK [added]; Falagas, Matthew [corrected to Falagas, Matthew E].
43. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME. Crit Care. 2005 Feb;9(1):R53-9. Epub 2005 Jan 6.